Also listed on Armagen, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 20, 2027 · High confidence
20-year base term ends Aug 20, 2027
Held by JCR Pharmaceuticals Co., Ltd.
Filed Aug 20, 2007 as application 11/841,623 · Granted Jun 22, 2010
Base term, 20 years from filing
Today
2007
2027
Clock starts
Aug 20, 2007
Aug 20, 2007
Term ends
Aug 20, 2027
Aug 20, 2027
Granted
Jun 22, 2010
Jun 22, 2010
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 20, 2007, when this application, 11/841,623, was filed | Aug 20, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 20, 2027 | High confidence |
This family
| US 7,741,446 | this patent Aug 2027 | Aug 2027 |
| US 8,753,610 | Lapsed on the fee record Jun 2026 | Jun 2026 |
| US 10,144,783 | Term ended Oct 2025 | Oct 2025 |
| US 11,155,631 | Lapsed on the fee record Oct 2025 | Oct 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 16, 2008 Reel 20370, frame 760 | Pardridge, William M.; Boado, Ruben J. | Armagen Technologies, Inc. | Assignment of Assignor's Interest |
| May 21, 2014 Reel 32971, frame 193 | Armagen Technologies, Inc. | National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. Government | Confirmatory License |
| Feb 2, 2018 Reel 44815, frame 135 | Armagen, Inc. | Oxford Finance LLC, as Collateral Agent and Lender | Security Interest |
| Nov 18, 2019 Reel 51042, frame 528 | Oxford Finance LLC | JCR Pharmaceuticals Co., Ltd. | Assignment of Assignor's Interest |
| Apr 11, 2020 Reel 52373, frame 585 | JCR Pharmaceuticals Co., Ltd. | Armagen, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Aug 2027
Term ends Aug 20, 2027. No further fees fall due before then
Citations
69
later US patents cite this one
That is top 10% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.